Mechanistic modeling of rodent liver tumor promotion at low levels of exposure: an example related to dose-response relationships for 2,3,7,8-tetrachlorodibenzo-p-dioxin

Abstract

Keywords

TCDD regional induction negative selection gene induction pharmacodynamics stochastic clone growth modeling

Get full access to this article

View all access options for this article.

References

Kociba RJ et al. Results of a Two-Year Chronic Toxicity and Oncogenicity Study of 2,3,7,8- Tetrachlorodibenzo-p-dioxin in Rats . Toxicol Appl Pharmacol 1978; 120: 138-154 .

NTP . 1982. Bioassays of 2,3,7,8- Tetrachlorodibenzo-p-dioxin for Possible Carcinogenicity (Gavage Study). National Toxicology Program, Technical Report Series No. 102, Research Triangle Park, NC .

Perdew G. Chemical Cross-Linking of the Cytosolic and Nuclear Forms of the Ah Receptor in Hepatoma Cell Line 1C1C7 . Biochem Biophys Res Commun 1992; 182: 55-63 .

TaiP-KK et al. Association of a 59-Kilodalton Immunophilin with the Glucocorticoid Receptor Complex . Science 1992; 256: 1315-1319 .

Enan E , Matsumura F. Identification of C-SRC as the Integral Component of the Cytosolic Ah Receptor Complex, Transducing the Signal of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) through the Protein Phosphorylation Pathway . Biochem Pharmacol 1996; 52: 1599-1612 .

Reyes H , Reisz-Porszasz S , Hankinson O. Identification of the Ah Receptor Nuclear Translocator Protein (Arnt) as a Component of the DNA Binding Form of the Ah Receptor . Science 1992; 256: 1193-1195 .

Bars RG , Elcombe CR. Dose-dependent Acinar Induction of Cytochromes P450 in Rat Liver: Evidence for a Differential Mechanism of Induction of P450IA1 by b-naphthoflavone and Dioxin . Biochem J 1991; 277: 577-580 .

Tritscher AM et al. Dose-Response Relationships for Chronic Exposure to 2,3,7,8- Tetrachlorodibenzo-p-dioxininaRatTumor Promotion Model: Quantification and Immunolocalization of CYP1A1 and CYP1A2 in the Liver . Cancer Res 1992; 52: 3436-3442 .

van Birgelen APJM et al. Relative Potencies of Polychlorinated Dibenzo-p-dioxins, Dibenzofurans and Biphenyls Derived from Hepatic Porphyrin Accumulation in Mice . Toxicol Appl Pharmacol 1996; 138: 98-109 .

10.

Maronpot RR et al. Dose Response for TCDD Promotion of Hepatocarcinogenesis in Rats Initiated with DEN: Histologic, Biochemical and Cell Proliferation Endpoints . Environ Health Perspec 1993; 101: 634-642 .

11.

Fox TR et al. Gene Expression and Cell Proliferation in Rat Liver after 2,3,7,8- tetrachlorodibenzo-p-dioxin Exposure . Cancer Res 1993; 53 (Suppl 10): 2265-2271 .

12.

Bauman JW , Goldsworthy TL , Dunn CS , Fox TR. Inhibitory Effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on Rat Hepatocyte Proliferation Induced by 2/3 Partial Hepatectomy . Cell Prolif 1995; 28: 437-451 .

13.

Pitot H et al. A Method to Quantitate the Relative Initiating and Promoting Potencies of Hepatocarcinogenic Agents in their Dose-Response Relationships to Altered Hepatic Foci . Carcinogenesis 1987; 8: 1491-1499 .

14.

Stinchcombe S , Buchmann A , Bock KW , Schwarz M. Inhibition of Apoptosis during 2,3,7,8- tetrachlorodibenzo-p-dioxin-mediated Tumour Promotion in Rat Liver . Carcinogenesis 1995; 16(6): 1271-1275 .

15.

Moolgavkar SH , Luebeck EG , Buchmann A , Bock KW. Quantitative Analysis of Enzyme-altered Liver Foci in Rats Initiated with Diethylnitrosamine and Promoted with 2,3,7,8-Tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-Heptachlorodibenzo-p-dioxin . Toxicol Appl Pharmacol 1996; 138: 31-42 .

16.

Portier CJ et al. Modeling the Number and Size of Hepatic Focal Lesions Following Exposure to 2,3,7,8-TCDD . Toxicol Appl Pharmacol 1996; 138: 20-30 .

17.

Rogers A , Andersen ME , Back KC. 1982. The Toxicity and Mutagenicity of 2,3,7,8- Tetrachlorodibenzo-p-dioxin and Similar Acting Compounds . Environmental Mutagen Society Meeting, Boston, MA .

18.

Yang J-H , Thraves P , Dritschilo A , Rhim JS. Neoplastic Transformation of Immortalized Human Keratinocytes by 2,3,7,8-Tetrachlorodibenzo-p-dioxin . Cancer Res 1992; 52: 3478-3482 .

19.

Jirtle RL , Meyer SA , Brockenbrough JS. (Eds) (1991). Liver Tumor Promoter Phenobarbital: A Biphasic Modulator of Hepatocyte Proliferation. In Chemically Induced Cell Proliferation: Implications for Risk Assessment. Wiley-Liss, Inc.

20.

Jirtle RL , Hankins GR , Reisenbichler B , Boyer IJ. Regulation of Mannose 6-Phosphate/Insulin-Like Growth Factor-II Receptors and Transforming Growth Factor Beta During Liver Tumor Promotion with Phenobarbital . Carcinogenesis 1994; 15: 1473-1478 .

21.

Andersen ME , Mills JJ , Jirtle RL , Greenlee WF. Negative Selection in Hepatic Tumor Promotion in Relation to Cancer Risk Assessment . Toxicology 1995; 102: 223-237 .

22.

Conolly RB , Andersen ME. Hepatic Foci in Rats after Diethylnitrosamine Initiation and 2,3,78- Tetrachloro-p-dioxin Promotion: Evaluation of a Quantitative Two-Cell Model and of CYP1A1/1A2 as a Dosimeter . Toxicol Appl Pharmacol 1997; 146: 281-293 .

23.

Leung HW , Ku RH , Paustenbach DJ , Andersen ME. A Physiologically Based Pharmacokinetic Model for 2,3,7,8-tetrachloro-p-dioxin in C57B1/6J and DBA/2J Mice . Toxicol Lett 1988; 42: 15-28 .

24.

Leung HW , Paustenbach DJ , Murray FJ , Andersen ME. A Physiological Pharmacokinetic Description of the Tissue Distribution and Enzyme Inducing Properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the Rat . Toxicol Appl Pharmacol 1990; 103: 399-410 .

25.

Andersen ME et al. Modeling Receptor-Mediated Processes with Dioxin: Implications for Pharmacokinetics and Risk Assessment . JRisk Anal 1993; 13: 25-36 .

26.

Kedderis LB , Mills JJ , Andersen ME , Birnbaum LS. A Physiologically Based Pharmacokinetic Model for 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in the Rat: Tissue Distribution and CYP1A Induction . Toxicol Appl Pharmacol 1993; 121: 87-98 .

27.

Kohn MC et al. A Mechanistic Model of the Effects of Dioxin on Gene Expression in the Rat Liver . Toxicol Appl Pharmacol 1993; 120: 138-154 .

28.

Andersen ME et al. A Multi-Compartment Geometric Model of the Liver in Relation to Regional Induction of Cytochrome P450s . Toxicol Appl Pharmacol 1997b; 144: 135-144 .

29.

Andersen ME , Birnbaum LS , Barton HA , Eklund C. Regional Hepatic CYP1A1 and CYP1A2 Induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin Evaluated with a Multi-Compartment Geometric Model of Hepatic Zonation . Toxicol Appl Pharmacol 1997a; 144: 145-155 .

30.

Andersen ME , Barton HA. Biological Regulation of Receptor-Hormone Complex Concentrations in Relation to Dose Response Assessments for Endocrine Active Compounds . Toxicological Sciences 1998; in press.

31.

Conolly RB , Kimbell JS. Computer Simulation of Cell Growth Governed by Stochastic Processes: Application to Clonal Growth Cancer Models . Toxicol Appl Pharmacol 1994; 124: 284-295 .

32.

Dewanji A , Venzon DJ , Moolgavkar SH. A Stochastic Two-Stage Model for Cancer Risk Assessment. II. The Number and Size of Premalignant Clones . Risk Anal 1989; 9: 179-187 .

33.

Haag-Gronlund M et al. Promotion of Altered Hepatic Foci by 2,3',4,4',5-Pentachlorobiphenyl in Sprague-Dawley Female Rats . Fundam Appl Toxicol 1997; 35: 120-130 .

34.

Matsumura F. How Important is the Protein Phosphorylation Pathway in the Toxic Expression of Dioxin-type Chemicals . Biochem Pharmacol 1994; 48: 215-224 .

35.

Enan E , Matsumura F. Evidence for a Second Pathway in the Action Mechanism of 2,3,7,8- Tetrachlorodibenzo-p-dioxin (TCDD). Significance of Ah-receptor Mediated Activation of Protein Kinase Under Cell-free Conditions . Biochem Pharmacol 1995; 49: 249-261 .

36.

Matsumura F et al. Altered In Vivo Toxicity of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in C-SRC Deficient Mice . Biochem Pharmacol 1997; 53: 1397-1404 .